Best Practices for Creating FASTA Files: Proper Defining of Sequence Records with the Greater-Than Sign (>)

In a FASTA file with multiple sequences, _____.A) each sequence record should begin with the identifier of the sequenceB) the definition line of each sequence record should start with the number sign (#)C) the definition line of each sequence record should start with the greater-than character (>)D) the end of a sequence should be marked by an asterisk (*)

C) the definition line of each sequence record should start with the greater-than character (>)

C) The definition line of each sequence record should start with the greater-than character (>).

In a FASTA file with multiple sequences, each sequence record should begin with the greater-than symbol (>), which is known as the header or definition line. The header line contains important information about the sequence, such as its name or unique identifier. Following the header line, the actual sequence data is presented as a string of characters that represents the nucleotides or amino acids.

Option A is incorrect because the identifier should be part of the header line, not necessarily the first line of the record.

Option B is incorrect because the number sign (#) is not used to represent the start of a header line in FASTA format.

Option D is incorrect because an asterisk (*) is not used to mark the end of a sequence in FASTA format. Instead, the end of a sequence is indicated simply by the start of a new header line.

More Answers:

Thorough Evaluation of Left Ventricular Wall Motion Using Echocardiography: Importance of Storing Real-Time Image Clips
Reduce Patient Exposure During Fluoroscopic Procedures: Effective Techniques
Challenges of Predicting Exon/Intron Borders for Eukaryotic Genomic DNA

Error 403 The request cannot be completed because you have exceeded your quota. : quotaExceeded

Share:

Recent Posts

Mathematics in Cancer Treatment

How Mathematics is Transforming Cancer Treatment Mathematics plays an increasingly vital role in the fight against cancer mesothelioma. From optimizing drug delivery systems to personalizing

Read More »